NL-OMON55822已完成不适用
Target finding for atherothrombosis in a population of patients diagnosed with peripheral obstructive arterial disease. - Target finding for atherothrombosis in PAD patients.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 315
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients diagnosed with peripheral artery disease, both new patients and
- •patients currently in follow-up
- •- Patients currently using Clopidogrel
- •- Patient provided signed declaration of consent
- •- Patients are at least 18 years of age and compos mentis.
排除标准
- •- Use of therapeutic doses of anticoagulants (Vitamin K antagonists, DOACs or
- •Low molecular weight heparins).
- •- Pregnancy, oral contraceptives, or hormone replacement therapy.
- •- Chronic inflammatory disease (e.g. RA, CU, MC).
- •- Anti-phospholipid syndrome (APS).
- •- Active malignancy.
研究者
相似试验
招募中
不适用
Contribution of coagulation and inflammation to the extent of atherosclerosis in patients with peripheral vascular diseaseNL-OMON21578Maatricht University315
进行中（未招募）
1 期
DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-label trialVenous thromboembolismCTIS2023-510186-98-00Academisch Ziekenhuis Leiden10,078
尚未招募
不适用
Discovery of Atherothrombosis Candidate Genes by Microarray of Platelets and Monocytes, Microarray on blood cells in Coronary Artery Disease1001108210003216Coronary Artery DiseaseMyocardial InfarctionNL-OMON30059Academisch Medisch Centrum50
已完成
不适用
Thrombosis Prevention TrialISRCTN63594484Sponsor not defined - Record provided by the Medical Research Council (UK)5,499
已完成
3 期
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)ArteriosclerosisNCT00050817Sanofi15,603